Rhumbline Advisers Has $63.17 Million Position in McKesson Co. (MCK)

Rhumbline Advisers lifted its stake in shares of McKesson Co. (NYSE:MCK) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 405,094 shares of the company’s stock after buying an additional 5,389 shares during the period. Rhumbline Advisers’ holdings in McKesson were worth $63,174,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Arizona State Retirement System boosted its position in shares of McKesson by 1.4% during the fourth quarter. Arizona State Retirement System now owns 52,820 shares of the company’s stock valued at $8,237,000 after buying an additional 744 shares during the last quarter. Capital Fund Management S.A. boosted its position in shares of McKesson by 505.8% during the fourth quarter. Capital Fund Management S.A. now owns 9,056 shares of the company’s stock valued at $1,412,000 after buying an additional 7,561 shares during the last quarter. State of Wisconsin Investment Board boosted its position in McKesson by 5.5% in the fourth quarter. State of Wisconsin Investment Board now owns 301,387 shares of the company’s stock worth $47,001,000 after purchasing an additional 15,683 shares during the last quarter. Squar Milner Financial Services LLC purchased a new position in McKesson in the fourth quarter worth $234,000. Finally, Point View Wealth Management Inc. boosted its position in McKesson by 12.4% in the fourth quarter. Point View Wealth Management Inc. now owns 5,630 shares of the company’s stock worth $878,000 after purchasing an additional 620 shares during the last quarter. 86.63% of the stock is currently owned by institutional investors.

Shares of McKesson Co. (NYSE MCK) opened at $150.50 on Friday. The stock has a market capitalization of $31,054.02, a price-to-earnings ratio of 12.00, a price-to-earnings-growth ratio of 1.37 and a beta of 1.23. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.07 and a quick ratio of 0.61. McKesson Co. has a one year low of $133.82 and a one year high of $178.86.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, February 1st. The company reported $3.41 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.92 by $0.49. The firm had revenue of $53.62 billion for the quarter, compared to analyst estimates of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the company posted $3.04 earnings per share. equities research analysts predict that McKesson Co. will post 12.71 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be paid a $0.34 dividend. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.36 annualized dividend and a dividend yield of 0.90%. McKesson’s payout ratio is presently 6.03%.

In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.20% of the company’s stock.

MCK has been the topic of several research analyst reports. Credit Suisse Group reissued a “sell” rating and issued a $130.00 price objective on shares of McKesson in a research report on Friday, February 2nd. Mizuho set a $168.00 price objective on McKesson and gave the stock a “hold” rating in a research report on Tuesday, October 24th. ValuEngine raised McKesson from a “hold” rating to a “buy” rating in a research report on Tuesday, October 31st. Zacks Investment Research raised McKesson from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a research report on Tuesday, December 26th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $173.00 price objective (down previously from $178.00) on shares of McKesson in a research report on Wednesday, November 1st. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company. McKesson presently has a consensus rating of “Hold” and an average target price of $177.50.

ILLEGAL ACTIVITY WARNING: “Rhumbline Advisers Has $63.17 Million Position in McKesson Co. (MCK)” was first published by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://weekherald.com/2018/02/18/rhumbline-advisers-has-63-17-million-position-in-mckesson-co-mck.html.

McKesson Profile

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply